|
|
|
|
Most-cited rankings are recalculated at the beginning of the month.
Rankings are based on citations to articles on this journal site from articles in HighWire-hosted journals.
| 1. | J Garthwaite, E Southam, CL Boulton, EB Nielsen, K Schmidt, B Mayer | ||
| Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one | |||
|---|---|---|---|
|
Mol Pharmacol Aug 01, 1995; 48: 184-188.
(In "ARTICLES") |
|||
| 2. | S Grissmer, AN Nguyen, J Aiyar, DC Hanson, RJ Mather, GA Gutman, MJ Karmilowicz, DD Auperin, KG Chandy | ||
| Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines | |||
|
Mol Pharmacol Jun 01, 1994; 45: 1227-1234.
(In "ARTICLES") |
|||
| 3. | Toshimasa Ishizaki, Masayoshi Uehata, Ichiro Tamechika, Jeongsin Keel, Kimiko Nonomura, Midori Maekawa, Shuh Narumiya | ||
| Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases | |||
|
Mol Pharmacol May 01, 2000; 57: 976-983.
(In "ARTICLES") |
|||
| 4. | K Williams | ||
| Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors | |||
|
Mol Pharmacol Oct 01, 1993; 44: 851-859.
(In "ARTICLES") |
|||
| 5. | Bryan Goodwin, Ecushla Hodgson, Christopher Liddle | ||
| The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module | |||
|
Mol Pharmacol Dec 01, 1999; 56: 1329-1339.
(In "ARTICLES") |
|||
| 6. | CM Flores, SW Rogers, LA Pabreza, BB Wolfe, KJ Kellar | ||
| A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment | |||
|
Mol Pharmacol Jan 01, 1992; 41: 31-37.
(In "ARTICLES") |
|||
| 7. | S Pippig, S Andexinger, MJ Lohse | ||
| Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization | |||
|
Mol Pharmacol Apr 01, 1995; 47: 666-676.
(In "ARTICLES") |
|||
| 8. | Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping, Caroline S. Hill | ||
SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor- Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7 |
|||
|
Mol Pharmacol Jul 01, 2002; 62: 65-74.
(In "ARTICLES") |
|||
| 9. | Tomas Barkhem, Bo Carlsson, Yvonne Nilsson, Eva Enmark, Jan-Åke Gustafsson, Stefan Nilsson | ||
Differential Response of Estrogen Receptor and Estrogen Receptor to Partial Estrogen Agonists/Antagonists |
|||
|
Mol Pharmacol Jul 01, 1998; 54: 105-112.
(In "ARTICLES") |
|||
| 10. | Yunhai Cui, Jörg König, Ulrike Buchholz, Herbert Spring, Inka Leier, Dietrich Keppler | ||
| Drug Resistance and ATP-Dependent Conjugate Transport Mediated by the Apical Multidrug Resistance Protein, MRP2, Permanently Expressed in Human and Canine Cells | |||
|
Mol Pharmacol May 01, 1999; 55: 929-937.
(In "ARTICLES") |
|||
| [Next 10 Articles] | |||